These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11132249)

  • 1. Antinociceptive effect induced by intraperitoneal administration of vitamin K2 (menatetrenone) in ICR mice.
    Onodera K; Shinoda H; Zushida K; Taki K; Kamei J
    Life Sci; 2000 Nov; 68(1):91-7. PubMed ID: 11132249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effect of vitamin K2 (menatetrenone) in diabetic mice.
    Onodera K; Zushida K; Kamei J
    Jpn J Pharmacol; 2001 Mar; 85(3):335-7. PubMed ID: 11325029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
    Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
    Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mexiletine on algogenic mediator-induced nociceptive responses in mice.
    Hitosugi H; Kashiwazaki T; Ohsawa M; Kamei J
    Methods Find Exp Clin Pharmacol; 1999; 21(6):409-13. PubMed ID: 10445233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity.
    Koshihara Y; Hoshi K; Shiraki M
    Biochem Pharmacol; 1993 Oct; 46(8):1355-62. PubMed ID: 8240383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
    Hara K; Akiyama Y; Tajima T; Shiraki M
    J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive profiles and mechanisms of centrally administered oxyntomodulin in various mouse pain models.
    Park SH; Lee JR; Jang SP; Park SH; Lee HJ; Hong JW; Suh HW
    Neuropeptides; 2018 Apr; 68():7-14. PubMed ID: 29366515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
    Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test.
    Mjellem-Joly N; Lund A; Berge OG; Hole K
    Pain; 1992 Nov; 51(2):195-198. PubMed ID: 1283010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models.
    Choi SS; Lee JK; Suh HW
    Brain Res; 2001 Dec; 921(1-2):233-9. PubMed ID: 11720731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures.
    Akiyama Y; Hara K; Tajima T; Murota S; Morita I
    Eur J Pharmacol; 1994 Sep; 263(1-2):181-5. PubMed ID: 7821350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formalin-induced nociceptive responses in diabetic mice.
    Kamei J; Hitosugi H; Kasuya Y
    Neurosci Lett; 1993 Jan; 149(2):161-4. PubMed ID: 7682680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDA.
    Masuyama T; Shimizu T
    Brain Res; 1997 Jun; 759(2):241-6. PubMed ID: 9221943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of menatetrenone on bone loss induced by ovariectomy in rats.
    Akiyama Y; Hara K; Ohkawa I; Tajima T
    Jpn J Pharmacol; 1993 Jun; 62(2):145-53. PubMed ID: 8371513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata L. in mice.
    Lapa Fda R; Gadotti VM; Missau FC; Pizzolatti MG; Marques MC; Dafré AL; Farina M; Rodrigues AL; Santos AR
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):306-15. PubMed ID: 19281602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats.
    Mawatari T; Miura H; Higaki H; Moro-Oka T; Kurata K; Murakami T; Iwamoto Y
    J Bone Miner Res; 2000 Sep; 15(9):1810-7. PubMed ID: 10977000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
    Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
    Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mexiletine on formalin-induced nociceptive responses in mice.
    Kamei J; Hitosugi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):153-62. PubMed ID: 7686682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.